Low within-and between-day variability in exposure to new insulin glargine 300 U/ml

被引：0
|
作者：
Becker, R. H. [1 ]
Nowotny, I. [1 ]
Teichert, L. [1 ]
Bergmann, K. [1 ]
Kapitza, C. [2 ]
机构：
[1] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany
[2] Profil, Neuss, Germany
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
953
引用
收藏
页码：S390 / S390
页数：1
相关论文
共 50 条
  • [41] THE REAL-WORLD DOSE DIFFERENCES OF INSULIN GLARGINE 300 U/ML IN FINLAND
    Koski, L.
    Hahl, J.
    Kaye, S.
    Pousar, K.
    VALUE IN HEALTH, 2019, 22 : S596 - S596
  • [42] Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives
    de Galan, Bastiaan E.
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 2097 - 2106
  • [43] Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
    Bolli, Geremia B.
    Cheng, Alice
    Charbonnel, Bernard
    Aroda, Vanita R.
    Westerbacka, Jukka
    Bosnyak, Zsolt
    Boelle-Le Corfec, Emmanuelle
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1588 - 1593
  • [44] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [45] Insulin glargine 300 units/mL: A new basal insulin product for diabetes mellitus
    Clements, Jennifer N.
    Bello, Larkin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 359 - 366
  • [46] Lower Glucose Variability and Risk for Hypoglycemia on Glargine 300 U/mL vs. Glargine 100 U/mL, Evaluated by the Low BG Index in Randomized Phase III Clinical Trials
    Kovatchev, Boris P.
    Meng, Zhaoling
    Breton, Marc D.
    Leroy, Bruno
    Cali, Anna
    DIABETES, 2017, 66 : A266 - A266
  • [47] Reproducible fluctuation Low Blood Levels in Insulin Glargine 300 E/ml
    Becker, R.
    Nowotny, I.
    Teichert, L.
    Bergmann, K.
    Kapitza, C.
    INTERNIST, 2015, 56 : 20 - 20
  • [48] Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
    Buscemi, Silvio
    Randazzo, Cristiana
    Buscemi, Carola
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1595 - 1596
  • [49] INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES
    Munshi, Medha N.
    Gill, Jasvinder
    Chao, Jason
    Nikonova, Elena V.
    Patel, Meenakshi
    ENDOCRINE PRACTICE, 2018, 24 (02) : 143 - 149
  • [50] Safety and efficacy of a pragmatic self-titration 1 unit/day (INSIGHT) algorithm for insulin glargine 300 U/mL (Gla-300)
    Yale, J. -F.
    Harris, S. B.
    Berard, L.
    Groleau, M.
    Javadi, P.
    Stewart, J.
    DIABETOLOGIA, 2016, 59 : S440 - S440
12345